BlackRock Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.51M Sell
111,434
-23,712
-18% -$331K ﹤0.01% 1645
2016
Q3
$1.66M Buy
135,146
+2,164
+2% +$25.5K ﹤0.01% 1554
2016
Q2
$1.46M Buy
132,982
+1,842
+1% +$20.6K ﹤0.01% 1592
2016
Q1
$1.43M Sell
131,140
-136,200
-51% -$1.72M ﹤0.01% 1581
2015
Q4
$4.62M Sell
267,340
-102,897
-28% -$1.84M ﹤0.01% 1123
2015
Q3
$7.36M Sell
370,237
-126,663
-25% -$2.9M 0.01% 929
2015
Q2
$8.16M Buy
496,900
+17,548
+4% +$304K 0.01% 822
2015
Q1
$7.46M Buy
479,352
+175,718
+58% +$2.72M 0.01% 870
2014
Q4
$4.34M Buy
303,634
+291,522
+2,407% +$3.08M ﹤0.01% 1003
2014
Q3
$79K Hold
12,112
﹤0.01% 3126
2014
Q2
$84K Sell
12,112
-2,393
-16% -$16.9K ﹤0.01% 3136
2014
Q1
$104K Buy
14,505
+4,645
+47% +$39.8K ﹤0.01% 3014
2013
Q4
$93K Buy
9,860
+497
+5% +$3.55K ﹤0.01% 3078
2013
Q3
$58K Sell
9,363
-3,150
-25% -$19.7K ﹤0.01% 3149
2013
Q2
$82K Buy
+12,513
New +$99.3K ﹤0.01% 3005

Other funds holding SCMP

BlackRock Advisors's SCMP Position: Q4 2016 in Review

BlackRock Advisors reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 18% in Q4 2016, selling an estimated $331K and leaving 111,434 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

BlackRock Advisors first reported a position in SCMP in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.16M in Q2 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

  • BlackRock Advisors held 111,434 shares of Sucampo Pharmaceuticals, Inc. worth $1.51M as of Q4 2016.
  • BlackRock Advisors sold 23,712 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $331K.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1645 holding.
  • BlackRock Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $8.16M in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.